Investigating Gene Expression Patterns in Dementia Patients: A Potential Early Biomarker for Alzheimer’s Disease

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Dementia is a severe neurodegenerative disorder commonly found in adults over 70 years of age. Alzheimer’s disease (AD) is the most prevalent type of dementia and currently has no therapeutic pathway able to effectively slow down or reverse progression of the disease. The insidious onset of AD manifests over 15 years and often, AD is left undiagnosed until the very end. This research aims to search for combinations of RNA-sequencing (RNAseq) gene expression patterns that can act as early biomarkers for AD. Provided by the Allen Brain Institute, this paper uses RNAseq expression values of 14 genes collected from 107 post-mortem brains in the hippocampus (HIP) and the forebrain white matter (FWM). Grouped according to dementia status, values were correlated and graphed against age, CERAD, NIA-Reagan scores and Braak stages. Qualitative deductions were initially made from bar graphs, in which, if concluded worthy of investigation, quantitative data analyses using Pearson’s correlation coefficient and T-tests were then conducted. From the obtained information, aging, dementia and brain area effects were taken and analyzed. Unexpectedly, genes with neuroprotective roles or are involved in growth of cells exhibited higher expression as age increases in dementia patients. The implications of overexpression of genes in dementia and AD may be a new topic worthy of further research for better understanding of such disorders. Additionally, majority of the notable trends were found in the FWM, the area of the brain often overlooked in research involving neurodegenerative diseases. Identification and analyses of these patterns offer means to investigate the subject from new angles. By using obtained information on potential early biomarkers to form parameters for larger and more advanced studies in this field, developing a full-fledged clinical practice for early diagnosis of AD seems attainable.
Full text 10,944 characters · extracted from preprint-html · click to expand
Investigating Gene Expression Patterns in Dementia Patients: A Potential Early Biomarker for Alzheimer’s Disease | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Investigating Gene Expression Patterns in Dementia Patients: A Potential Early Biomarker for Alzheimer’s Disease Ydathip Phetchrungruengphol This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-1968398/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Dementia is a severe neurodegenerative disorder commonly found in adults over 70 years of age. Alzheimer’s disease (AD) is the most prevalent type of dementia and currently has no therapeutic pathway able to effectively slow down or reverse progression of the disease. The insidious onset of AD manifests over 15 years and often, AD is left undiagnosed until the very end. This research aims to search for combinations of RNA-sequencing (RNAseq) gene expression patterns that can act as early biomarkers for AD. Provided by the Allen Brain Institute, this paper uses RNAseq expression values of 14 genes collected from 107 post-mortem brains in the hippocampus (HIP) and the forebrain white matter (FWM). Grouped according to dementia status, values were correlated and graphed against age, CERAD, NIA-Reagan scores and Braak stages. Qualitative deductions were initially made from bar graphs, in which, if concluded worthy of investigation, quantitative data analyses using Pearson’s correlation coefficient and T-tests were then conducted. From the obtained information, aging, dementia and brain area effects were taken and analyzed. Unexpectedly, genes with neuroprotective roles or are involved in growth of cells exhibited higher expression as age increases in dementia patients. The implications of overexpression of genes in dementia and AD may be a new topic worthy of further research for better understanding of such disorders. Additionally, majority of the notable trends were found in the FWM, the area of the brain often overlooked in research involving neurodegenerative diseases. Identification and analyses of these patterns offer means to investigate the subject from new angles. By using obtained information on potential early biomarkers to form parameters for larger and more advanced studies in this field, developing a full-fledged clinical practice for early diagnosis of AD seems attainable. Full Text Additional Declarations There is NO conflict of interest to disclose. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-1968398","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":372170436,"identity":"59ccbfa4-27ca-4aa4-a2a6-7b3af82a054e","order_by":0,"name":"Ydathip Phetchrungruengphol","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAyElEQVRIiWNgGAWjYFCCBAZmBgMGORDzwAMitTA2A7UYg7UkEK+FgSGxAWIjEcDgePLzxwUFd9Lnhx1+CLTFTk63gZCWM88Mm2cYPMvdeDvNAKgl2djsACEtNxIMm3kMDudunJ0A0nIgcRthLekfQVrSDWenfyBWSw7YlgR56RwibZE886ZwNo/BM8MN0jkFBxIMiPAL3/H0DZ95/tyRl5+dvvnDhwo7OYJaFCAKDjAYgBkGBJSDgHwDVAuUMQpGwSgYBaMAEwAAmgNNiSM/7hkAAAAASUVORK5CYII=","orcid":"","institution":"The Newton Sixth Form School","correspondingAuthor":true,"prefix":"","firstName":"Ydathip","middleName":"","lastName":"Phetchrungruengphol","suffix":""}],"badges":[],"createdAt":"2022-08-16 16:46:03","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-1968398/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-1968398/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":67948899,"identity":"3ffa02c9-4450-4306-95d1-6133db40039c","added_by":"auto","created_at":"2024-10-31 14:59:37","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3127205,"visible":true,"origin":"","legend":"","description":"","filename":"InvestigatingGeneExpressionPatternsinDementiaPatientsAPotentialEarlyBiomarkerforAlzheimerXXXsDisease.pdf","url":"https://assets-eu.researchsquare.com/files/rs-1968398/v1_covered_83665b5b-d607-424b-9689-41ef1c178c49.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e conflict of interest to disclose.","formattedTitle":"Investigating Gene Expression Patterns in Dementia Patients: \nA Potential Early Biomarker for Alzheimer’s Disease","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-1968398/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-1968398/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eDementia is a severe neurodegenerative disorder commonly found in adults over 70 years of age. Alzheimer\u0026rsquo;s disease (AD) is the most prevalent type of dementia and currently has no therapeutic pathway able to effectively slow down or reverse progression of the disease. The insidious onset of AD manifests over 15 years and often, AD is left undiagnosed until the very end. This research aims to search for combinations of RNA-sequencing (RNAseq) gene expression patterns that can act as early biomarkers for AD. Provided by the Allen Brain Institute, this paper uses RNAseq expression values of 14 genes collected from 107 post-mortem brains in the hippocampus (HIP) and the forebrain white matter (FWM). Grouped according to dementia status, values were correlated and graphed against age, CERAD, NIA-Reagan scores and Braak stages. Qualitative deductions were initially made from bar graphs, in which, if concluded worthy of investigation, quantitative data analyses using Pearson\u0026rsquo;s correlation coefficient and T-tests were then conducted. From the obtained information, aging, dementia and brain area effects were taken and analyzed. Unexpectedly, genes with neuroprotective roles or are involved in growth of cells exhibited higher expression as age increases in dementia patients. The implications of overexpression of genes in dementia and AD may be a new topic worthy of further research for better understanding of such disorders. Additionally, majority of the notable trends were found in the FWM, the area of the brain often overlooked in research involving neurodegenerative diseases. Identification and analyses of these patterns offer means to investigate the subject from new angles. By using obtained information on potential early biomarkers to form parameters for larger and more advanced studies in this field, developing a full-fledged clinical practice for early diagnosis of AD seems attainable.\u003c/p\u003e","manuscriptTitle":"Investigating Gene Expression Patterns in Dementia Patients: \nA Potential Early Biomarker for Alzheimer’s Disease","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-10-31 14:51:26","doi":"10.21203/rs.3.rs-1968398/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"a4e932f3-ecae-4bb4-9f74-31c4d1af8801","owner":[],"postedDate":"October 31st, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2024-10-31T14:51:26+00:00","versionOfRecord":[],"versionCreatedAt":"2024-10-31 14:51:26","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-1968398","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-1968398","identity":"rs-1968398","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00